Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IX1A
|
||||
Former ID |
DAP001144
|
||||
Drug Name |
Pentolinium
|
||||
Synonyms |
Pentolineum; Pentolonium; Pentolonum; 1,1'-pentane-1,5-diylbis(1-methylpyrrolidinium); 1-methyl-1-[5-(1-methylpyrrolidin-1-ium-1-yl)pentyl]pyrrolidin-1-ium
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypotension [ICD9: 458, 796.3; ICD10:I95] | Approved | [1] | ||
Therapeutic Class |
Antihypertensive Agents
|
||||
Company |
Wyeth Ayerst Laboratories
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H32N2+2
|
||||
Canonical SMILES |
C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C
|
||||
InChI |
1S/C15H32N2/c1-16(12-6-7-13-16)10-4-3-5-11-17(2)14-8-9-15-17/h3-15H2,1-2H3/q+2
|
||||
InChIKey |
XSBSKEQEUFOSDD-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 52-62-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, alpha-4 chain | Target Info | Antagonist | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Cholinergic synapse | |||||
Nicotine addiction | |||||
PANTHER Pathway | Nicotinic acetylcholine receptor signaling pathway | ||||
Nicotine pharmacodynamics pathway | |||||
Reactome | Highly sodium permeable acetylcholine nicotinic receptors | ||||
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | |||||
Highly calcium permeable nicotinic acetylcholine receptors | |||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
References | |||||
REF 1 | Drug information of Pentolinium, 2008. eduDrugs. | ||||
REF 2 | Nicotinic and nonnicotinic receptor-mediated actions of vinblastine. Proc Soc Exp Biol Med. 1993 Jul;203(3):372-6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.